Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Completed Phase 1 Trials for Alvocidib (DB03496)

IndicationStatusPhase
DBCOND0028534 (Adult Acute Minimally Differentiated Myeloid Leukemia (M0))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00470197Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute LeukemiaTreatment